关注
Ahmed Ullah Mishuk
Ahmed Ullah Mishuk
其他姓名Mishuk A.U, AU Mishuk, A Mishuk
NIH, Clinical Center, Clinical Epidemiology Section
在 nih.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
Medicinal potential of Passiflora foetida L. plant extracts: biological and pharmacological activities
M Asadujjaman, AU Mishuk, MA Hossain, UK Karmakar
Journal of integrative medicine 12 (2), 121-126, 2014
532014
Novel approaches in lipid based drug delivery systems
MD Asadujjaman, AU Mishuk
Journal of Drug Delivery and Therapeutics 3 (4), 124-130, 2013
352013
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017
QJ Mishuk AU, Chen L, Gaillard P, Westrick S, Hansen RA
Journal of the American Pharmacists Association 61 (1), 87-94. e7, 2021
302021
Impact of US federal and state generic drug policies on drug use, spending, and patient outcomes-A systematic review
AU Mishuk, I Fasani, J Qian
Research in Social and Administrative Pharmacy, 2019
222019
The association between patient sociodemographic characteristics and generic drug use: a systematic review and meta-analysis
AU Mishuk, J Qian, JN Howard, I Harris, G Frank, Z Kiptanui, R Hansen
Journal of managed care & specialty pharmacy 24 (3), 252-264, 2018
192018
Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug …
SM Fahim, AU Mishuk, N Cheng, R Hansen, AI Calderón, J Qian
Expert Opinion on Drug Safety 18 (2), 145-152, 2019
102019
A survey on traditional medicinal plants used for the treatment of diabetes in urban areas of Dhaka and Khulna, Bangladesh
MM Rahman, A Mishuk, S Halder, ASS Rouf
Glob. J. Med. Res. Pharma Drug Disc. Toxicol. Med 13, 21-26, 2013
92013
Safety of dietary supplements use among patients with cancer: A systematic review
Z Zeng, AU Mishuk, J Qian
Critical reviews in oncology/hematology 152, 103013, 2020
82020
Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugs
J Qian, AU Mishuk, RA Hansen
Expert Opinion on Drug Safety 17 (8), 753-756, 2018
72018
Comparative analysis of adverse drug reactions in directly observed treatment short course (DOTS) in TB patients
MM Rahman, A Mishuk, S Halder, AKL Kabir
Glob J Med Res 13, 6-10, 2013
42013
Assessment of phytochemical & pharmacological activities of the ethanol extracts of Xanthium indicum
AU Mishuk, MA Rahman, S Afrin, MI Ahmed, SK Sadhu, F Hossain
International Journal of Pharmaceutical Sciences and Research 3 (12), 4811, 2012
42012
Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study
N Huo, L Chen, A Ullah Mishuk, C Li, RA Hansen, I Harris, Z Kiptanui, ...
Endocrine 68, 336-348, 2020
32020
Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in US Hospitals: A Retrospective Cohort Study
JR Strich, A Mishuk, G Diao, A Lawandi, W Li, CY Demirkale, A Babiker, ...
Annals of internal medicine 177 (5), 559-572, 2024
22024
652. Ceftazidime-avibactam alone or as combination therapy? Multicenter retrospective cohort analysis of clinical outcomes in patients with carbapenem-resistant Gram-negative …
AU Mishuk, JR Strich, S Warner, J Sun, S Malik, A Lawandi, M Kondo, ...
Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 704, 2022
12022
Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study
AU Mishuk, L Chen, C Li, N Huo, RA Hansen, I Harris, Z Kiptanui, J Qian
Current Medical Research and Opinion 37 (4), 655-664, 2021
12021
Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study
C Li, L Chen, N Huo, AU Mishuk, RA Hansen, I Harris, Z Kiptanui, Z Wang, ...
Plos one 15 (4), e0232226, 2020
12020
Signals in types of adverse event reporting of concurrent use of botanical dietary supplements and anticancer prescriptions in the US Food and Drug Administration adverse event …
J Qian, SM Fahim, AU Mishuk, A Calderon, R Hansen
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 249-249, 2018
12018
Generic substitution patterns of levothyroxine and escitalopram in subgroups of US Medicare beneficiaries
J Qian, C Li, N Huo, AU Mishuk, L Chen, R Hansen, I Harris, Z Kiptanui
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 438-438, 2018
12018
1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in US Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market …
JR Strich, A Ullah Mishuk, A Lawandi, G Diao, S Warner, W Li, ...
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 083, 2023
2023
1649. Ceftolozane-Tazobactam or Ceftazidime-Avibactam Versus Best Available Therapy in the Treatment of Difficult-to-Treat Pseudomonas aeruginosa Infections: a Retrospective …
A Lawandi, AU Mishuk, C Yek, A Yu, X Li, JR Strich, S Sarzynski, ...
Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 115, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20